These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 27838783)

  • 21. Fibroblast growth factor 23, Klotho, and disordered mineral metabolism in chronic kidney disease: unraveling the intricate tapestry of events and implications for therapy.
    Gutiérrez OM
    J Ren Nutr; 2013 May; 23(3):250-4. PubMed ID: 23611556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormonal regulation of phosphate balance].
    Tanaka H; Fukagawa M
    Clin Calcium; 2012 Oct; 22(10):1477-85. PubMed ID: 23023626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The FGF23/KLOTHO Regulatory Network and Its Roles in Human Disorders.
    Kinoshita S; Kawai M
    Vitam Horm; 2016; 101():151-74. PubMed ID: 27125741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
    Nakatani T; Sarraj B; Ohnishi M; Densmore MJ; Taguchi T; Goetz R; Mohammadi M; Lanske B; Razzaque MS
    FASEB J; 2009 Feb; 23(2):433-41. PubMed ID: 18835926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on FGF23 and Klotho signaling.
    Erben RG
    Mol Cell Endocrinol; 2016 Sep; 432():56-65. PubMed ID: 27178987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Klotho in bone and implication for CKD.
    Komaba H; Lanske B
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):298-304. PubMed ID: 29697410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
    Kuro-o M
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Klotho in health and disease.
    Kuro-o M
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):362-8. PubMed ID: 22660551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
    Kuro-O M
    Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF23 and klotho at the intersection of kidney and cardiovascular disease.
    Edmonston D; Grabner A; Wolf M
    Nat Rev Cardiol; 2024 Jan; 21(1):11-24. PubMed ID: 37443358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D; Friedlander G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Klotho and phosphate metabolism].
    Yokoyama K
    Clin Calcium; 2012 Oct; 22(10):1531-6. PubMed ID: 23023633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
    Bai X; Dinghong Q; Miao D; Goltzman D; Karaplis AC
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E79-88. PubMed ID: 18984852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
    de Seigneux S; Martin PY
    Pharmacol Res; 2016 Apr; 106():87-91. PubMed ID: 26900884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.
    Hu MC; Shi M; Moe OW
    Pflugers Arch; 2019 Jan; 471(1):99-108. PubMed ID: 30506274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A potential link between phosphate and aging].
    Shiizaki K; Kuro-o M
    Clin Calcium; 2012 Oct; 22(10):1493-8. PubMed ID: 23023628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
    Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.